InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: None

Tuesday, 12/12/2017 12:56:21 AM

Tuesday, December 12, 2017 12:56:21 AM

Post# of 44784
And for those who wonder why people's opinions may have changed from the beginning of the year to now, look at the following from their Jan 2017 presentation.
.
-Data readout dose selection studies ARS-H12017
-Contract with U.S government for ARS-H2/2017
-Initiation of pivotal study ARS NHP- H2/2017
-Data read out phase 1 open label HCT-H2/2017
-Preclinical data Fukushima-H1/17
-Preclinical data NYBC H1/2017

One out of six. That's acceptable right? That's what you want from management right? Experience really isn't important right? Huge bonuses in the same year is an industry norm and perfectly justified when you are under a month away from missing 5 of your 6 beginning of the year milestones right? Give us 5 out of 6 and it would probably be a different story. Or the big one that would make a big difference.

What would be so wrong to actually come out and explain the delays in any or all of these. Two of them coming up on 6 months late. Nothing to worry about there. Just normal delays. Ya right. Pathetic management is what we are stuck with unfortunately. Just do a few scripted interviews and speeches and that should shut them up.

Someone once asked a philosophical question. Who's the bigger idiot? The idiot or the one who believes the idiot? Think about it... Go ahead and cut and copy it and try to poke fun. You know it's true. LMBO